-
2026년 표적치료연구회 춘계학술대회
일시 : 2026년 3월 14일(토)
장소 : 전북대병원 지하 1층 모악홀
| Time | Title | Speaker & Chairperson |
|---|---|---|
| 09:30-10:45 | 등록 | |
| 10:45-11:00 | 개회사 | 장윤수 (표적치료연구회 회장) |
| 축사 | 우홍균 (대한폐암학회 이사장) | |
| 프로그램 소개 | 엄상원 (표적치료연구회 학술위원장) | |
| 11:00-12:15 | Session 1: NSCLC without actionable genetic alterations after first-line chemo-immunotherapy |
좌장 김희정 (건국의대) |
| 11:00-11:25 | Current landscape of second-line treatment | 최수인 (고려의대) |
| 11:25-11:50 | How to overcome primary resistance to first-line chemo-immunotherapy | 김규연 (가톨릭의대) |
| 11:50-12:15 | Novel therapeutic options and treatment sequencing strategies | 유우경 (인하의대) |
| 12:15-13:10 | Lunch | |
| 13:10-14:00 | Session 2: NSCLC with actionable genetic alterations beyond first-line TKIs |
좌장 박순효 (계명의대) |
| 13:10-13:35 | EGFR-mutated NSCLC after first-line monotherapy or combination therapy | 윤성훈 (부산의대) |
| 13:35-14:00 | ALK, ROS1, and RET fusion-positive NSCLC after first-line TKI | 구강모 (중앙의대) |
| 14:00-14:15 | Coffee Break | |
| 14:15-15:05 | Session 3: Emerging new therapeutic targets and diagnostic approaches |
좌장 최창민 (울산의대) |
| 14:15-14:40 | Emerging therapeutic targets in NSCLC | 이은혜 (연세의대) |
| 14:40-15:05 | Future perspectives on robotic bronchoscopy | 이태훈 (울산의대) |
| 15:05-15:20 | Coffee Break | |
| 15:20-16:35 | Session 4: Management strategies for SCLC after 1ˢᵗ-line chemo-immunotherapy |
좌장 오인재 (전남의대) |
| 15:20-15:45 | Emerging molecular subtypes and therapeutic implications | 정재욱 (충남의대) |
| 15:45-16:10 | Tarlatamab and other DLL3-targeted therapy | 김미현 (부산의대) |
| 16:10-16:35 | Antibody–drug conjugates and novel agents beyond DLL3-targeted therapy | 강혜린 (한림의대) |
| 16:35-16:45 | 숙제보고 | 손지웅 (건양의대) |
| 16:45- | 폐회 |